C1846545 |
Autoimmune Lymphoproliferative Syndrome Type 2B |
DO |
autoimmune lymphoproliferative syndrome type 2B
|
0110116 |
C1846545 |
Autoimmune Lymphoproliferative Syndrome Type 2B |
MONDO |
autoimmune lymphoproliferative syndrome type 2B
|
0011804 |
C1846545 |
Autoimmune Lymphoproliferative Syndrome Type 2B |
MSH |
Autoimmune Lymphoproliferative Syndrome
|
D056735 |
C1846545 |
Autoimmune Lymphoproliferative Syndrome Type 2B |
MSH |
Autoimmune Lymphoproliferative Syndrome Type 2B
|
D056735 |
C1846545 |
Autoimmune Lymphoproliferative Syndrome Type 2B |
MSH |
Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant
|
D056735 |
C1846545 |
Autoimmune Lymphoproliferative Syndrome Type 2B |
OMIM |
CASPASE 8 DEFICIENCY
|
607271 |
C1846545 |
Autoimmune Lymphoproliferative Syndrome Type 2B |
OMIM |
CEDS
|
607271 |
C1846545 |
Autoimmune Lymphoproliferative Syndrome Type 2B |
ORDO |
Autoimmune lymphoproliferative syndrome with recurrent viral infections
|
275517 |